IP Library Granted Patent US 7,759,307
Granted Patent B2
US 7,759,307 · App. 11/651,161 · Granted Jul 20, 2010

Compositions for protection against superficial vasodilator flush syndrome, and methods of use

Assignee: Theta Biomedical Consulting & Development Co., Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,759,307
App. No.
11/651,161
Granted
Jul 20, 2010
Kind
B2
Abstract

Compositions for protection against SVFS syndromes are composed of a flavonoid compound of the basic structures 2-phenyl-4H-1-benzopyran or 2-phenyl-4-keto-1-benzopyran or glycosides thereof, an inventive olive kernel extract and a non-bovine sulfated proteoglycan, and, optionally, one or more of bitter willow extract, D-glucosamine sulfate and serotonin inhibitor.

Claims (1)

1. A method of treating niacin-induced flush consisting of administering to a patient in need thereof, an effective dose of a flavonoid compound, a non-bovine sulfated proteoglycan, and olive kernel oil; wherein said flavonoid is selected from quercetin and luteolin.

Assignments (2)
MERGER Recorded Apr 12, 2022
From: THETA BIOMEDICAL CONSULTING AND DEVELOPMENT CO., INC.
To: THETA BIOMEDICAL CONSULTING AND DEVELOPMENT, LLC
Reel/Frame 060005/0100 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2010
From: THEOHARIDES, THEOHARIS C.
To: THETA BIOMEDICAL CONSULTING & DEVELOPMENT CO., INC.
Reel/Frame 024499/0535 →
Continuity (2)
Continuation In Part 1081182800 · Mar 30, 2004
Related Publication 20070141187A1 · Jun 21, 2007